CARERAY DIGITAL MEDICAL TECHNOLOGY CO., LTD. CareRay Digital Medical Technology Co., Ltd. Stock
Equities
688607
CNE100004BR9
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.41 CNY | +1.75% |
|
+15.31% | -34.20% |
| Sales 2023 | 274M 37.78M | Sales 2024 * | 345M 47.61M | Capitalization | 1.18B 163M |
|---|---|---|---|---|---|
| Net income 2023 | 15M 2.07M | Net income 2024 * | 29M 4M | EV / Sales 2023 | 6.56 x |
| Net cash position 2023 * | - 0 | Net cash position 2024 * | - 0 | EV / Sales 2024 * | 3.43 x |
| P/E ratio 2023 |
120
x | P/E ratio 2024 * |
40.6
x | Employees | - |
| Yield 2023 |
0.26% | Yield 2024 * |
-
| Free-Float | 53.62% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.75% | ||
| 1 week | +15.31% | ||
| Current month | -11.31% | ||
| 1 month | -3.53% | ||
| 3 months | -19.80% | ||
| 6 months | -26.56% | ||
| Current year | -34.20% |
1 week
11.16
13.75
1 month
10.8415.79
Current year
9.7121.20
1 year
9.7122.75
3 years
9.7164.44
5 years
9.7185.22
10 years
9.7185.22
| Managers | Title | Age | Since |
|---|---|---|---|
Jian Qiang Liu
CEO | Chief Executive Officer | 62 | 07-05-22 |
Tao Guo
CHM | Chairman | 43 | 18-06-30 |
Ping Zhang
DFI | Director of Finance/CFO | 46 | 07-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Qiang Liu
CEO | Chief Executive Officer | 62 | 07-05-22 |
Xin Hua Jiang
BRD | Director/Board Member | 61 | 21-05-19 |
Mei Qi Wang
BRD | Director/Board Member | 60 | 18-02-08 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 13.41 | +1.75% | 2,300,809 |
| 24-04-25 | 13.18 | +3.45% | 1,674,888 |
| 24-04-24 | 12.74 | +0.39% | 2,080,199 |
| 24-04-23 | 12.69 | +6.82% | 3,232,591 |
| 24-04-22 | 11.88 | +2.15% | 2,384,835 |
End-of-day quote Shanghai S.E., April 25, 2024
More quotes
CareRay Digital Medical Technology Co Ltd is a China-based company mainly engaged in the research and development, production, sales and service of digital X-ray flat panel detectors. The Company's product applications have gradually extended from medical general radiography to breast, dynamic fluoroscopy, radiotherapy, oral three-dimensional imaging and other fields, and further expanded to the fields of industry, security, and pet medical care. The Company's products are sold to domestic and foreign markets.
Calendar
2024-08-15
- Q2 2024 Earnings Release (Projected)
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -34.20% | 163M | |
| -5.77% | 14.68B | |
| -40.71% | 2.71B | |
| -12.92% | 2.44B | |
| -8.78% | 1.51B | |
| -.--% | 1.12B | |
| +40.66% | 518M | |
| +91.79% | 502M | |
| +1.67% | 183M | |
| -.--% | 168M |
- Stock Market
- Equities
- 688607 Stock
